8-K Announcements
6Material company update
Apr 7, 2026·SEC
Material company update
Feb 13, 2026·SEC
Material company update
Feb 3, 2026·SEC
Nutriband Inc.(NTRB)Earnings, Financials & Key Ratios
NTRB•NASDAQ
$3.97
$48M mkt cap·Price updated May 6, 2026
AboutNutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Show more
- Revenue$2M-4.8%
- EBITDA-$8M-26.8%
- Net Income-$8M+21.5%
- EPS (Diluted)-2.58-160.6%
- Gross Margin25.68%-21.4%
- EBITDA Margin-398.9%-33.3%
- Operating Margin-408.41%-30.6%
- Net Margin-404.08%+17.5%
- ROE-125.56%+22.9%
- ROIC-270.2%-128.6%
- Debt/Equity0.03+8.3%
- Interest Coverage-369.11+24.5%
NTRB Key Insights
Nutriband Inc. (NTRB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 16.6%
✗Weaknesses
- ✗Profits declining 20.7% over 5 years
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 14 (bottom 14%)
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NTRB Price & Volume
Nutriband Inc. (NTRB) stock price & volume — 10-year historical chart
Loading chart...
NTRB Growth Metrics
Nutriband Inc. (NTRB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years16.63%
3 Years-0.69%
TTM-4.81%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM21.49%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-166.63%
Return on Capital
10 Years-355.09%
5 Years-74.65%
3 Years-97.47%
Last Year-125.55%
NTRB Peer Comparison
Nutriband Inc. (NTRB) competitors in Drug Delivery Technology Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DARE | 27.49M | 3.16 | -6.58 | -99.65% | -6.11% | |||
 AVDL | 2.1B | 21.64 | -42.43 | 5.05% | -0.11% | -0.33% | 0.02 | |
 MTUS | 795.8M | 19.07 | -666.78 | 6.85% | 0.24% | 0.42% | 0.02 | |
 CLRB | 14.97M | 3.53 | -0.42 | -248.91% | 0.04 | |||
 PRGO | 1.69B | 12.26 | -1.19 | -2.75% | -43.5% | -50.65% | 1.35 | |
 LPCN | 13.17M | 2.43 | -1.44 | -82.35% | -487.05% | -59.29% | ||
 NKTR | 1.67B | 85.09 | -8.75 | -43.89% | -192.87% | -356.81% | 0.95 | |
 HALO | 7.81B | 66.35 | 25.92 | 37.55% | 22.69% | 6.49% |
Compare NTRB vs Peers
Nutriband Inc. (NTRB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NTRB Income Statement
Nutriband Inc. (NTRB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 245.28K | 370.65K | 943.7K | 1.42M | 2.08M | 2.09M | 2.14M | 2.04M |
| Revenue Growth % | - | - | 51.11% | 154.61% | 50.7% | 46.23% | 0.27% | 2.62% | -4.83% |
| Cost of Goods Sold | 0 | 288.3K | 549.11K | 582.38K | 917.84K | 1.33M | 1.22M | 1.44M | 1.51M |
| COGS % of Revenue | - | 117.54% | 148.15% | 61.71% | 64.54% | 63.92% | 58.66% | 67.29% | 74.32% |
| Gross Profit | 0▲ 0% | -43.02K▲ 0% | -178.46K▼ 314.9% | 361.32K▲ 302.5% | 504.31K▲ 39.6% | 750.41K▲ 48.8% | 862.11K▲ 14.9% | 699.3K▼ 18.9% | 523.11K▼ 25.2% |
| Gross Margin % | - | -17.54% | -48.15% | 38.29% | 35.46% | 36.08% | 41.34% | 32.68% | 25.68% |
| Gross Profit Growth % | - | - | -314.87% | 302.47% | 39.57% | 48.8% | 14.88% | -18.88% | -25.2% |
| Operating Expenses | 171.95K | 3.29M | 1.79M | 2.96M | 4.43M | 4.9M | 5.73M | 7.39M | 8.84M |
| OpEx % of Revenue | - | 1340.57% | 483.2% | 313.37% | 311.8% | 235.54% | 274.97% | 345.28% | 434.1% |
| Selling, General & Admin | 171.95K | 3.29M | 1.79M | 2.96M | 4.02M | 3.92M | 3.77M | 4.27M | 6.95M |
| SG&A % of Revenue | - | 1340.57% | 483.2% | 313.37% | 282.87% | 188.31% | 180.96% | 199.53% | 341.24% |
| Research & Development | 0 | 0 | 0 | 0 | 411.38K | 982.23K | 1.96M | 3.12M | 1.89M |
| R&D % of Revenue | - | - | - | - | 28.93% | 47.23% | 94.01% | 145.75% | 92.85% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -171.95K▲ 0% | -3.33M▼ 1837.4% | -1.97M▲ 40.9% | -2.6M▼ 31.8% | -3.93M▼ 51.4% | -4.15M▼ 5.5% | -4.87M▼ 17.5% | -6.69M▼ 37.3% | -8.32M▼ 24.3% |
| Operating Margin % | - | -1358.11% | -531.35% | -275.08% | -276.33% | -199.45% | -233.63% | -312.62% | -408.41% |
| Operating Income Growth % | -13.68% | -1837.38% | 40.88% | -31.81% | -51.39% | -5.55% | -17.46% | -37.32% | -24.33% |
| EBITDA | -24.69K | -3.29M | -1.88M | -2.43M | -3.61M | -3.78M | -4.58M | -6.4M | -8.12M |
| EBITDA Margin % | - | -1343.02% | -506.57% | -257.1% | -253.96% | -181.71% | -219.83% | -299.3% | -398.9% |
| EBITDA Growth % | - | -13244.52% | 43% | -29.22% | -48.86% | -4.63% | -21.31% | -39.72% | -26.84% |
| D&A (Non-Cash Add-back) | 147.26K | 37.01K | 91.84K | 169.72K | 318.26K | 368.96K | 287.72K | 285.05K | 193.8K |
| EBIT | -2.67M | -3.33M | -2.65M | -2.65M | -6.06M | -4.48M | -5.41M | -10.46M | -8.32M |
| Net Interest Income | 0 | 0 | -73.41K | -349.82K | -118.42K | -8.29K | -58.97K | 170.26K | 88.33K |
| Interest Income | 0 | 0 | 0 | 280.69K | 0 | 0 | 16.85K | 191.67K | 110.86K |
| Interest Expense | 0 | 0 | 73.41K | 280.69K | 118.42K | 8.29K | 75.81K | 21.41K | 22.54K |
| Other Income/Expense | -2.5M | 0 | -752.19K | -336.88K | -2.25M | -335.62K | -613.39K | -3.79M | 88.33K |
| Pretax Income | -2.67M▲ 0% | -3.33M▼ 24.7% | -2.72M▲ 18.3% | -2.93M▼ 7.8% | -6.18M▼ 110.6% | -4.48M▲ 27.4% | -5.49M▼ 22.3% | -10.48M▼ 91.1% | -8.23M▲ 21.5% |
| Pretax Margin % | - | -1358.11% | -734.29% | -310.78% | -434.28% | -215.59% | -263.05% | -489.86% | -404.08% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.67M▲ 0% | -3.33M▼ 24.7% | -2.8M▲ 16.1% | -3.21M▼ 15.0% | -8.42M▼ 162.1% | -4.81M▲ 42.9% | -5.49M▼ 14.0% | -10.48M▼ 91.1% | -8.23M▲ 21.5% |
| Net Margin % | - | -1358.11% | -754.1% | -340.52% | -592.23% | -231.33% | -263.05% | -489.86% | -404.08% |
| Net Income Growth % | -1666.46% | -24.67% | 16.1% | -14.97% | -162.09% | 42.88% | -14.02% | -91.11% | 21.5% |
| Net Income (Continuing) | -2.67M | -3.33M | -2.72M | -2.93M | -6.18M | -4.48M | -5.49M | -10.48M | -8.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.48▲ 0% | -0.53▼ 10.4% | -0.44▲ 17.0% | -0.48▼ 9.1% | -1.06▼ 120.8% | -0.57▲ 46.2% | -0.69▼ 21.1% | -0.99▼ 43.5% | -2.58▼ 160.6% |
| EPS Growth % | -1820% | -10.42% | 16.98% | -9.09% | -120.83% | 46.23% | -21.05% | -43.48% | -160.61% |
| EPS (Basic) | -0.48 | -0.53 | -0.44 | -0.48 | -1.06 | -0.57 | -0.69 | -0.99 | -2.58 |
| Diluted Shares Outstanding | 5.6M | 6.24M | 6.33M | 6.73M | 7.93M | 8.46M | 7.95M | 10.61M | 11.64M |
| Basic Shares Outstanding | 5.6M | 6.24M | 6.33M | 6.73M | 7.93M | 8.46M | 7.95M | 10.61M | 11.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
NTRB Balance Sheet
Nutriband Inc. (NTRB) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 164.9K | 590.47K | 43.18K | 314.19K | 5.47M | 2.69M | 1.02M | 4.79M | 4.99M |
| Cash & Short-Term Investments | 0 | 474.65K | 10.18K | 151.99K | 4.89M | 1.99M | 492.94K | 4.31M | 4.57M |
| Cash Only | 0 | 474.65K | 10.18K | 151.99K | 4.89M | 1.99M | 492.94K | 4.31M | 4.57M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 263 | 13.09K | 12.83K | 109.35K | 71.38K | 113.05K | 148.65K | 73.85K | 118.4K |
| Days Sales Outstanding | - | 19.48 | 12.64 | 42.29 | 18.32 | 19.84 | 26.02 | 12.6 | 21.22 |
| Inventory | 4.13K | 0 | 0 | 52.85K | 131.65K | 229.34K | 168.6K | 212.04K | 117.99K |
| Days Inventory Outstanding | - | - | 0 | 33.12 | 52.35 | 62.98 | 50.31 | 53.75 | 28.45 |
| Other Current Assets | 0 | 102.72K | 0 | 0 | 0 | 0 | 0 | -546 | 177.47K |
| Total Non-Current Assets | 0 | 2.22M | 2.15M | 9.61M | 7.27M | 6.76M | 6.5M | 2.68M | 2.56M |
| Property, Plant & Equipment | 0 | 146.15K | 120.64K | 1.08M | 998.34K | 960.49K | 806.3K | 695.06K | 639.25K |
| Fixed Asset Turnover | - | 1.68x | 3.07x | 0.88x | 1.42x | 2.17x | 2.59x | 3.08x | 3.19x |
| Goodwill | 0 | 1.72M | 1.72M | 7.53M | 5.35M | 5.02M | 5.02M | 1.72M | 1.72M |
| Intangible Assets | 0 | 351.77K | 314.7K | 1.01M | 926.91K | 780.43K | 667.28K | 261.09K | 200.43K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -63 | 0 |
| Total Assets | 164.9K▲ 0% | 2.81M▲ 1602.6% | 2.2M▼ 21.7% | 9.93M▲ 351.7% | 12.74M▲ 28.3% | 9.46M▼ 25.8% | 7.52M▼ 20.5% | 7.47M▼ 0.6% | 7.55M▲ 1.0% |
| Asset Turnover | - | 0.09x | 0.17x | 0.10x | 0.11x | 0.22x | 0.28x | 0.29x | 0.27x |
| Asset Growth % | 337.08% | 1602.63% | -21.72% | 351.71% | 28.33% | -25.77% | -20.51% | -0.63% | 1.04% |
| Total Current Liabilities | 43.39K | 403.01K | 2.02M | 2.57M | 779.26K | 748.61K | 999.09K | 982.85K | 784.28K |
| Accounts Payable | 12.34K | 291.78K | 771.93K | 0 | 0 | 0 | 680.13K | 698.82K | 0 |
| Days Payables Outstanding | - | 369.41 | 513.11 | - | - | - | 202.95 | 177.13 | - |
| Short-Term Debt | 31.05K | 40K | 311.57K | 1.52M | 14.12K | 19.74K | 127.18K | 128.14K | 161.32K |
| Deferred Revenue (Current) | -43.39K | 71.22K | 0 | 86.85K | 106.27K | 162.9K | 157.5K | 155.88K | 120.3K |
| Other Current Liabilities | 0 | 0 | 928.77K | 940.61K | 639.54K | 534.68K | 0 | 0 | 502.65K |
| Current Ratio | 3.80x | 1.47x | 0.02x | 0.12x | 7.01x | 3.60x | 1.02x | 4.88x | 6.36x |
| Quick Ratio | 3.71x | 1.47x | 0.02x | 0.10x | 6.84x | 3.29x | 0.85x | 4.66x | 6.21x |
| Cash Conversion Cycle | - | - | -500.48 | - | - | - | -126.62 | -110.79 | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 246.87K | 101.12K | 134.77K | 79.83K | 58.2K | 84.17K |
| Long-Term Debt | 0 | 0 | 0 | 150.06K | 101.12K | 100.5K | 79.83K | 58.2K | 48.3K |
| Capital Lease Obligations | 0 | 0 | 0 | 96.8K | 0 | 34.28K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.86K |
| Total Liabilities | 43.39K | 403.01K | 2.02M | 2.82M | 880.38K | 883.39K | 1.08M | 1.04M | 868.45K |
| Total Debt | 31.05K | 40K | 321.62K | 1.79M | 134.57K | 185.81K | 241.28K | 186.35K | 209.63K |
| Net Debt | 31.05K | -434.65K | 311.44K | 1.64M | -4.76M | -1.8M | -251.66K | -4.13M | -4.37M |
| Debt / Equity | 0.26x | 0.02x | 1.83x | 0.25x | 0.01x | 0.02x | 0.04x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -36.07x | -9.45x | -51.15x | -539.89x | -71.35x | -488.67x | -369.11x |
| Total Equity | 121.51K▲ 0% | 2.4M▲ 1879.0% | 175.43K▼ 92.7% | 7.11M▲ 3953.9% | 11.86M▲ 66.8% | 8.57M▼ 27.7% | 6.44M▼ 24.9% | 6.43M▼ 0.1% | 6.68M▲ 3.9% |
| Equity Growth % | 425.8% | 1878.97% | -92.7% | 3953.94% | 66.75% | -27.71% | -24.9% | -0.14% | 3.9% |
| Book Value per Share | 0.02 | 0.39 | 0.03 | 1.06 | 1.49 | 1.01 | 0.81 | 0.61 | 0.57 |
| Total Shareholders' Equity | 121.51K | 2.4M | 175.43K | 7.11M | 11.86M | 8.57M | 6.44M | 6.43M | 6.68M |
| Common Stock | 20.88K | 21.7K | 5.44K | 6.26K | 9.15K | 7.83K | 8.86K | 11.07K | 12.16K |
| Retained Earnings | -2.85M | -6.18M | -8.9M | -11.84M | -18.01M | -22.49M | -27.98M | -38.46M | -46.69M |
| Treasury Stock | 0 | 0 | 0 | 0 | -104.47K | -32.64K | -32.64K | -149K | 0 |
| Accumulated OCI | -446 | -52 | -304 | -304 | -304 | -304 | -304 | -304 | -304 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NTRB Cash Flow Statement
Nutriband Inc. (NTRB) cash flow — operating, investing & free cash flow history
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -92.86K | -1.11M | -894.47K | -297.06K | -2.81M | -2.99M | -3.53M | -4.63M | -5.13M |
| Operating CF Margin % | - | -450.69% | -241.33% | -31.48% | -197.53% | -143.64% | -169.16% | -216.22% | -252.11% |
| Operating CF Growth % | 37.23% | -1090.49% | 19.09% | 66.79% | -845.69% | -6.34% | -18.09% | -31.17% | -10.97% |
| Net Income | -2.67M | -3.33M | -2.72M | -2.93M | -6.18M | -4.48M | -5.49M | -10.48M | -8.23M |
| Depreciation & Amortization | 0 | 37.01K | 91.41K | 169.72K | 318.26K | 368.96K | 287.72K | 285.05K | 193.8K |
| Stock-Based Compensation | 0 | 1.76M | 252.7K | 2M | 897.83K | 732.13K | 742.7K | 1.54M | 104.4K |
| Deferred Taxes | 0 | 0 | 678.77K | -12.93K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.5M | 24.3K | 91.32K | 363.89K | 2.23M | 614.51K | 704.17K | 3.99M | 2.8M |
| Working Capital Changes | 75.09K | 400.51K | 712.96K | 110.23K | -541.38K | -219.32K | 223.22K | 34.09K | 0 |
| Change in Receivables | 0 | -12.82K | 255 | -94.75K | 42.97K | -41.66K | -153.97K | 74.8K | -44.56K |
| Change in Inventory | 3.92K | 4.13K | -720.15K | -10.23K | -78.8K | -97.69K | 60.73K | -43.44K | 94.05K |
| Change in Payables | 4K | 337.98K | 720.15K | 155.22K | -145.26K | -104.86K | 198.89K | 23.61K | 120.94K |
| Cash from Investing | 92.89K | -404.16K | 0 | 66.99K | -81.59K | -79.3K | -51.76K | -92.04K | -5.32K |
| Capital Expenditures | 0 | -4.16K | 0 | 0 | -81.59K | -79.3K | -51.76K | -92.04K | 0 |
| CapEx % of Revenue | - | 1.7% | - | - | 5.74% | 3.81% | 2.48% | 4.3% | - |
| Acquisitions | 0 | -400K | 0 | 66.99K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -404.16K | 0 | 66.99K | -81.59K | -79.3K | 0 | 0 | -5.32K |
| Cash from Financing | 65.76K | 1.98M | 430.25K | 371.87K | 7.63M | 160.07K | 2.09M | 8.54M | 5.4M |
| Debt Issued (Net) | 7.51K | 22.42K | 425K | -161.54K | -1.63M | -17.8K | 2.09M | 8.69M | 0 |
| Equity Issued (Net) | 50K | 1.5M | 0 | 515.11K | 6.31M | -119.01K | 0 | -149K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | -196.59K | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -104.47K | -119.01K | 0 | -149K | 0 |
| Other Financing | 8.25K | 461.47K | 5.25K | 18.31K | 3.14M | 296.88K | 0 | 69 | 5.4M |
| Net Change in Cash | 65.76K▲ 0% | 474.65K▲ 621.8% | -464.47K▼ 197.9% | 141.81K▲ 130.5% | 4.74M▲ 3242.4% | -2.91M▼ 161.3% | -1.49M▲ 48.6% | 3.82M▲ 355.9% | 263.14K▼ 93.1% |
| Free Cash Flow | -92.86K▲ 0% | -1.11M▼ 1095.0% | -894.47K▲ 19.4% | -297.06K▲ 66.8% | -2.89M▼ 873.2% | -3.07M▼ 6.1% | -3.58M▼ 16.7% | -4.72M▼ 31.8% | -5.13M▼ 8.8% |
| FCF Margin % | - | -452.38% | -241.33% | -31.48% | -203.27% | -147.46% | -171.64% | -220.51% | -252.11% |
| FCF Growth % | 37.23% | -1094.97% | 19.39% | 66.79% | -873.16% | -6.08% | -16.72% | -31.84% | -8.81% |
| FCF per Share | -0.02 | -0.18 | -0.14 | -0.04 | -0.36 | -0.36 | -0.45 | -0.44 | -0.44 |
| FCF Conversion (FCF/Net Income) | 0.03x | 0.33x | 0.32x | 0.09x | 0.33x | 0.62x | 0.64x | 0.44x | 0.62x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NTRB Key Ratios
Nutriband Inc. (NTRB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -2599.19% | -3695.2% | -263.74% | -216.67% | -88.19% | -88.79% | -47.09% | -73.08% | -162.94% | -125.56% |
| Return on Invested Capital (ROIC) | -4136.55% | -162.2% | -235.42% | -120.24% | -42.17% | -37.19% | -44.84% | -56.39% | -118.2% | -270.2% |
| Gross Margin | - | - | -17.54% | -48.15% | 38.29% | 35.46% | 36.08% | 41.34% | 32.68% | 25.68% |
| Net Margin | - | - | -1358.11% | -754.1% | -340.52% | -592.23% | -231.33% | -263.05% | -489.86% | -404.08% |
| Debt / Equity | 0.45x | 0.26x | 0.02x | 1.83x | 0.25x | 0.01x | 0.02x | 0.04x | 0.03x | 0.03x |
| Interest Coverage | - | - | - | -36.07x | -9.45x | -51.15x | -539.89x | -71.35x | -488.67x | -369.11x |
| FCF Conversion | 0.98x | 0.03x | 0.33x | 0.32x | 0.09x | 0.33x | 0.62x | 0.64x | 0.44x | 0.62x |
| Revenue Growth | - | - | - | 51.11% | 154.61% | 50.7% | 46.23% | 0.27% | 2.62% | -4.83% |
NTRB SEC Filings & Documents
Nutriband Inc. (NTRB) SEC filings — annual & quarterly reports (10-K, 10-Q)
NTRB Frequently Asked Questions
Nutriband Inc. (NTRB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Nutriband Inc. (NTRB) reported $2.0M in revenue for fiscal year 2025.
Nutriband Inc. (NTRB) saw revenue decline by 4.8% over the past year.
Nutriband Inc. (NTRB) reported a net loss of $8.2M for fiscal year 2025.
Dividend & Returns
Nutriband Inc. (NTRB) has a return on equity (ROE) of -125.6%. Negative ROE indicates the company is unprofitable.
Nutriband Inc. (NTRB) had negative free cash flow of $5.1M in fiscal year 2025, likely due to heavy capital investments.
Explore More NTRB
Nutriband Inc. (NTRB) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates